1 not yet recruiting, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Epoetin: new trials by email Literature Review of Epoetin trials Research Report on Epoetin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies Luspatercept, Epoetin - Luspatercept, Epoetin | Phase 2 / Phase 3 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 90 | 2026-06-15 | 2026-06-09 |
| EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT) Epogen, Normal Saline - Cardiac Surgery-CABG, Cardiac Valve Replacement | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 4 | 2015-05-01 | 2019-02-26 |
Johns Hopkins University (1) · Nanfang Hospital, Southern Medical University (1)
China (1) · United States (1)
Keith A. Horvath, MD (1) · Qifa Liu (1)